3.9800.13% ( +0.005 )
Delay Closed: Nov 18, 16:08:04News
Best Numbers, Worst Tape: Hong Kong's Small-Cap Split
Global Report·- In October 2026, Hong Kong small-cap stocks showed a decoupling between performance and stock prices, with capital shifting to reprice AI narratives and real earnings. - Stocks with strong fundamentals or realized AI revenue, such as JD Health and Huazhu Group, saw steady gains, while those relying on projected AI themes experienced severe volatility despite high profit growth or losses. - The market is no longer pricing stocks strictly by sector, instead drawing a clear line between companies with confirmed AI-driven revenue and those depending purely on forward-looking expectations.Duty-Free Expansion and Retail Resilience Highlight Hong Kong's Sector Divergence
Global Report·- China Tourism Group Duty Free Corporation secured the duty-free project at Beijing Capital International Airport T3, while Chow Tai Fook reported positive third-quarter sales growth. - JD Health achieved a revenue of 17.45 billion in the second quarter of 2025 with a 24.5% year-over-year increase, and Fosun Pharma advanced its pipeline through regulatory acceptance and strategic acquisitions. - Sunac China faced ongoing debt pressure with over 2.14 billion in new enforcement records, reflecting continued divergence across Hong Kong stock market sectors.
